<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Intraischemic mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> has been shown to be neuroprotective in reducing <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> in transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>As a more clinical relevant issue, we investigated the effect of delayed intraischemic and postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> on <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> in a rat model of reversible focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We also examined the effect of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> on the <z:mp ids='MP_0001845'>inflammatory response</z:mp> after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion to assess the neuroprotective mechanism of brain <z:hpo ids='HP_0002045'>hypothermia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Rats were subjected to 2 hours of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by 22 hours of reperfusion under the following protocols: (1) rats were treated with normothermia (37.0 degrees C, 4 hours) and then housed in room temperature (25 degrees C, 18 hours) and (2) rats were treated with <z:hpo ids='HP_0002045'>hypothermia</z:hpo> (33.0 degrees C, 4 hours, brain temperature modulation was started 30 minutes before the reperfusion) and then housed in cold temperature (5 degrees C, 18 hours) </plain></SENT>
<SENT sid="4" pm="."><plain>Animals were killed 24 hours after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was examined with 2,3,5-triphenyl-tetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining </plain></SENT>
<SENT sid="6" pm="."><plain>The accumulation of polymorphonuclear leukocytes (PMNLs) and the expression of intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 mRNA were evaluated in both groups </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: A significant reduction (P&lt;0.05) in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was found in the <z:hpo ids='HP_0002045'>hypothermia</z:hpo> group compared with the normothermia group </plain></SENT>
<SENT sid="8" pm="."><plain>Compared with the normothermia group, hypothermic treatment also significantly reduced the accumulation of PMNLs (P&lt;0.01) and inhibited the overexpression of intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 mRNA at 22 hours of reperfusion after 2 hours of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Ischemic brain damage can be reduced with delayed intraischemic and prolonged postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> in a focal model of transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="10" pm="."><plain>The neuroprotective mechanism of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> may be mediated by suppression of PMNL-mediated <z:mp ids='MP_0001845'>inflammatory response</z:mp> after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion in this model </plain></SENT>
</text></document>